Life‑sciences‑focused Business ModelA focused product and services mix for regulated life‑sciences creates durable demand: compliance, regulatory, clinical and quality workflows are sticky, require specialized software and services, and drive multi‑year engagements and recurring revenue potential if market traction returns.

Balance Sheet Improvement In FY2025Restored positive equity and zero reported debt materially reduce near‑term solvency risk and increase optionality; a debt‑free position provides financial flexibility to invest in product/market stabilization or absorb operating deficits without immediate refinancing.

Proven Ability To Generate Operating Cash HistoricallyPrior periods of strong operating and free cash flow show the underlying business model can generate internal funding when revenue and operations perform, implying recoverable economics and a pathway to self‑funding if operational trends reverse.

Bears Say

Revenue Collapsed To Zero In FY2025Reported zero revenue in FY2025 is a fundamental durability risk: without core sales the firm cannot sustainably cover operating costs, undermines customer traction and long‑term viability, and forces reliance on one‑off or non‑operating items to report positive net income.

Inconsistent Cash Generation; Recent Negative Operating Cash FlowVolatile and recently negative operating cash flow weakens the firm’s ability to self‑fund recovery or investments. Even with zero debt, recurring negative OCF increases the likelihood of external financing, dilution or spending cuts that impair long‑term growth execution.

Balance‑sheet Volatility And Prior Negative EquityA prior episode of negative equity signals past solvency stress and raises counterparty, supplier and investor caution. Such swings reduce confidence in financial stability and can constrain partnerships, contract terms, and access to capital even after headline recovery.

TAKE Solutions Limited News

TAKE Solutions Appoints New Non-Executive Director

TAKE Solutions Limited ( ($IN:TAKE) ) has provided an update. TAKE Solutions Limited has announced the appointment of...

3M ago

TAKE

TAKE Solutions Announces Director Resignation

The latest announcement is out from TAKE Solutions Limited ( ($IN:TAKE) ). TAKE Solutions Limited has announced the...

3M ago

TAKE

TAKE FAQ

What was TAKE Solutions Limited’s price range in the past 12 months?

TAKE Solutions Limited lowest stock price was ₹6.70 and its highest was ₹49.90 in the past 12 months.

What is TAKE Solutions Limited’s market cap?

TAKE Solutions Limited’s market cap is ₹5.37B.

When is TAKE Solutions Limited’s upcoming earnings report date?

TAKE Solutions Limited’s upcoming earnings report date is May 28, 2026 which is in 82 days.

How were TAKE Solutions Limited’s earnings last quarter?

TAKE Solutions Limited released its earnings results on Feb 14, 2026. The company reported ₹0.076 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.076.

Is TAKE Solutions Limited overvalued?

According to Wall Street analysts TAKE Solutions Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does TAKE Solutions Limited pay dividends?

TAKE Solutions Limited pays a Semiannually dividend of ₹0.4 which represents an annual dividend yield of N/A. See more information on TAKE Solutions Limited dividends here

What is TAKE Solutions Limited’s EPS estimate?

TAKE Solutions Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TAKE Solutions Limited have?

TAKE Solutions Limited has 147,934,000 shares outstanding.

What happened to TAKE Solutions Limited’s price movement after its last earnings report?

TAKE Solutions Limited reported an EPS of ₹0.076 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.976%.

Which hedge fund is a major shareholder of TAKE Solutions Limited?

Currently, no hedge funds are holding shares in IN:TAKE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

TAKE Solutions Limited

TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe. The company offers IP-driven and technology backed solutions, consulting, and functional services across clinical, regulatory, and safety for life sciences industry. It also provides clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. In addition, the company provides IT infrastructure and support, supply chain management, engineering, designing, and sourcing services. It serves to large and small innovator biopharmaceutical and devices companies, as well as generics manufacturers. The company was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.